The global Active Pharmaceutical Ingredients (API) market is set for steady expansion over the next decade, driven by rising pharmaceutical production, increasing chronic disease prevalence, and advancements in biopharmaceutical manufacturing technologies. Valued at USD 250.9 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2035,...